These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15683066)

  • 21. Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy.
    Gilson AM; Maurer MA; Ryan KM; Skemp-Brown M; Husain A; Cleary JF
    J Pain Palliat Care Pharmacother; 2011; 25(3):246-51. PubMed ID: 21882978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brazilian public policies for reproductive health: family planning, abortion and prenatal care.
    Guilhem D; Azevedo AF
    Dev World Bioeth; 2007 Aug; 7(2):68-77. PubMed ID: 17614992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug supplies in primary care units at the Ministry of Health in Mexico].
    Gómez-Dantés O; Garrido-Latorre F; Tirado-Gómez LL; Ramírez D; Macías C
    Salud Publica Mex; 2001; 43(3):224-32. PubMed ID: 11452699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adherence to essential medicines in cities from three Brazilian states].
    Dal Pizzol Tda S; Trevisol DJ; Heineck I; Flores LM; Camargo AL; Köenig A; Torres IL; Kadri MC; Monreal MT; Melo AM; Ferreira MB
    Cad Saude Publica; 2010 Apr; 26(4):827-36. PubMed ID: 20512222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential medicines for the whole world.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Nov; 82(5):500-3. PubMed ID: 17952105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs.
    Chaudhury RR; Parameswar R; Gupta U; Sharma S; Tekur U; Bapna JS
    Health Policy Plan; 2005 Mar; 20(2):124-36. PubMed ID: 15746221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organization and delivery of primary health care services in Petrópolis, Brazil.
    Macinko J; Almeida C; dos SE; de Sá PK
    Int J Health Plann Manage; 2004; 19(4):303-17. PubMed ID: 15688875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Availability of essential medicines in primary health care of the Brazilian Unified Health System.
    Nascimento RCRMD; Álvares J; Guerra AA; Gomes IC; Costa EA; Leite SN; Costa KS; Soeiro OM; Guibu IA; Karnikowski MGO; Acurcio FA
    Rev Saude Publica; 2017 Nov; 51(suppl 2):10s. PubMed ID: 29160448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].
    Yamauti SM; Barberato-Filho S; Lopes LC
    Cad Saude Publica; 2015 Aug; 31(8):1648-62. PubMed ID: 26375644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Making drugs accessible.
    Association La Bergerie
    AIDS Action; 1999; (43):5. PubMed ID: 12349193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
    Tetteh Ek
    Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential drugs in primary health centres of north central Nigeria; where is Bamako initiative?
    Sambo MN; Lewis I; Sabitu K
    Niger J Clin Pract; 2008 Mar; 11(1):9-13. PubMed ID: 18689131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Health Commons and care of New Mexico's uninsured.
    Kaufman A; Derksen D; Alfero C; DeFelice R; Sava S; Tomedi A; Baptiste N; Jaeger L; Powell W
    Ann Fam Med; 2006; 4 Suppl 1(Suppl 1):S22-7; discussion S58-60. PubMed ID: 17003158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Essential drugs and pharmaceutical care: reflection on the access to drugs through lawsuits in Brazil].
    Sant'ana JM; Pepe VL; Osorio-de-Castro CG; Ventura M
    Rev Panam Salud Publica; 2011 Feb; 29(2):138-44. PubMed ID: 21437372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Access to essential medicines in Africa: a global approach].
    Millot G
    Med Trop (Mars); 2006 Dec; 66(6):558-64. PubMed ID: 17286021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
    Hale VG; Woo K; Lipton HL
    Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of follow-on drugs and indications on the WHO Essential Drug List.
    Cohen J; Cabanilla L; Sosnov J
    J Clin Pharm Ther; 2006 Dec; 31(6):585-92. PubMed ID: 17176363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.